Artivion Inc.
Organization details
- Legal name
- Artivion Inc.
- Former names
- Cryolife Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Kennesaw
- Headquarters state / province
- Georgia
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- AORT
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000784199
- EIN
- 59-2417093
- Wikidata ID
- Q5190505
Board of directors
-
Anthony B. Semedo · DirectorSince 2023
-
Daniel J. Bevevino · DirectorSince 2023
-
Elizabeth A. Hoff · DirectorSince 2023
-
James Bullock · DirectorSince 2023
-
Jeffrey H. Burbank · DirectorSince 2023
-
Jon W. Salveson · DirectorSince 2023
-
Marna P. Borgstrom · DirectorSince 2023
-
Thomas F. Ackerman · DirectorSince 2023
Director election results
Annual meeting of May 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
87.1%
-
94.9%
-
95.2%
-
95.2%
-
96.8%
-
96.9%
-
99.8%
-
99.8%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Nuwellis Inc. Same sectorvia Jon W. Salveson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $19,004,566
- 58 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | GREEN ANDREW M Officer (SVP, Regulatory and Quality) | Open-market sale | −11,480 | $24.97 | $286,656 |
| Sep 3, 2026 | GREEN ANDREW M Officer (SVP, Regulatory and Quality) | Open-market sale | −1,493 | $26.02 | $38,848 |
| Sep 2, 2026 | GREEN ANDREW M Officer (SVP, Regulatory and Quality) | Open-market sale | −6,510 | $27.27 | $177,528 |
| Aug 19, 2026 | Mackin James P Officer (President & CEO) | Open-market sale | −70,000 | $28.96 | $2,027,200 |
| Aug 14, 2026 | Lance A. Berry Officer (EVP, COO, CFO & Treasurer) | Open-market sale | −715 | $28.55 | $20,413 |
| Aug 14, 2026 | GREEN ANDREW M Officer (SVP, Regulatory and Quality) | Open-market sale | −616 | $28.55 | $17,587 |
| Aug 12, 2026 | Holloway Jean F Officer (SVP, General Counsel) | Open-market sale | −977 | $28.49 | $27,835 |
| Jun 11, 2026 | GREEN ANDREW M Officer (SVP, Regulatory and Quality) | Option exercise | +14,001 | $18.44 | $258,178 |
| Jun 11, 2026 | GREEN ANDREW M Officer (SVP, Regulatory and Quality) | Open-market sale | −14,001 | $20.71 | $289,961 |
| Jun 11, 2026 | GREEN ANDREW M Officer (SVP, Regulatory and Quality) | Option exercise | +30,000 | $11.03 | $330,900 |
| Jun 11, 2026 | GREEN ANDREW M Officer (SVP, Regulatory and Quality) | Open-market sale | −30,000 | $20.69 | $620,700 |
| Jun 2, 2026 | Anthony B. Semedo Director | Other | −6,325 | — | — |
| Jun 2, 2026 | Anthony B. Semedo Director | Other | +6,325 | — | — |
| May 18, 2026 | Anthony B. Semedo Director | Grant or award | +7,576 | — | — |
| May 18, 2026 | Jon W. Salveson Director | Grant or award | +7,576 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Artivion Inc.
How many directors are on Artivion Inc.'s board?
Artivion Inc.'s board has 8 directors: Anthony B. Semedo, Daniel J. Bevevino, Elizabeth A. Hoff, James Bullock, Jeffrey H. Burbank, Jon W. Salveson, Marna P. Borgstrom and Thomas F. Ackerman.
Are Artivion Inc. insiders buying or selling shares?
Over the last 12 months, Artivion Inc. insiders made no open-market purchases and sold $19.0 million of shares in 58 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="artivion-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.